T Masaoka

Human urinary macrophage colony-stimulating factor reduces the incidence and duration of febrile neutropenia and shortens the period required to finish three courses of intensive consolidation therapy in acute myeloid leukemia: a double-blind controlled study.

R Ohno, S Miyawaki, Kiyohiko Hatake et al. · Journal of Clinical Oncology · 1997 · 61 citations

Clinical effects of recombinant human granulocyte colony-stimulating factor in leukemia patients: a phase I/II study.

Hirofumi Teshima, Junya Ishikawa, H Kitayama et al. · PubMed · 1989 · 53 citations

A randomized controlled study of granulocyte colony stimulating factor after intensive induction and consolidation therapy in patients with acute lymphoblastic leukemia. Japan Adult Leukemia Study Group.

R Ohno, Masao Tomonaga, Takashi Ohshima et al. · PubMed · 1993 · 36 citations

Phase II Study of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor in Myelodysplastic Syndrome and Aplastic Anemia

Masuhiro Takahashi, Yataro Yoshida, Kohei Kaku et al. · Acta Haematologica · 1993 · 14 citations

Hematological Malignancy, Myelodysplastic Syndrome, Autoimmune Disease +13

Classification of acute non-lymphocytic leukemia according to the distribution picture of peroxidase activity and cell size: correlation between the classification and therapeutic response.

T Takubo, Yawara Kubota, S Oguma et al. · PubMed · 1983 · 10 citations

Mixed-phenotype Acute Leukemia, Immunology, Blood Cell +18